2023
DOI: 10.1164/rccm.202206-1223oc
|View full text |Cite|
|
Sign up to set email alerts
|

Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 39 publications
(16 citation statements)
references
References 37 publications
0
15
1
Order By: Relevance
“…In addition, our findings are in agreement with previous research showing that CPAP 42 -but also NSO 43 can reduce measures of increased sympathetic traffic. In contrast, this study shows that individuals with OSA and a low ΔHR, which has also been linked to increased cardiovascular risk in population studies, 32,44 did not exhibit a reduction in BP with treatment. This result is in agreement with our prior hypothesis that people with a low ΔHR do not seem to benefit from therapy, 32,35 potentially due to pathogenic modifications related to cardiovascular morbidity that go beyond OSA pathogenesis and, thus, are unlikely to be ameliorated by OSA treatment.…”
Section: Baseline δHr As a Predictor Of A Favorable Treatment Effect ...contrasting
confidence: 89%
“…In addition, our findings are in agreement with previous research showing that CPAP 42 -but also NSO 43 can reduce measures of increased sympathetic traffic. In contrast, this study shows that individuals with OSA and a low ΔHR, which has also been linked to increased cardiovascular risk in population studies, 32,44 did not exhibit a reduction in BP with treatment. This result is in agreement with our prior hypothesis that people with a low ΔHR do not seem to benefit from therapy, 32,35 potentially due to pathogenic modifications related to cardiovascular morbidity that go beyond OSA pathogenesis and, thus, are unlikely to be ameliorated by OSA treatment.…”
Section: Baseline δHr As a Predictor Of A Favorable Treatment Effect ...contrasting
confidence: 89%
“…It is also worth considering in future whether emerging technologies could be used to better quantify OSA severity in train drivers, rather than relying on self-report, screeners and/or single night polysomnography (PSG). New metrics of OSA severity, including measures of hypoxia 36 , 37 , sleep fragmentation 38 , 39 and autonomic responses 40 , 41 have been shown to better predict cardio-metabolic risk associated with OSA. The implementation of these approaches in this worker population may also be helpful in future for identifying workers at risk of significant incidents, and should be considered where possible in future analyses.…”
Section: Discussionmentioning
confidence: 99%
“…S olelhac et al [ 8 ] evaluated the association between pulse wave amplitude drops (PWAD) index and incident or recurrent cardiovascular events in three prospective cohorts: HypnoLaus (general population), ISAACC (acute coronary syndrome with OSA), and the Pays de la Loire Sleep Cohort (OSA cohort). The study aimed to investigate the value of PWAD as a biomarker of cardiovascular risk in OSA, related to sympathetic activation and vasoreactivity.…”
Section: Year In Review: Advances In Sleep Breathing Disordersmentioning
confidence: 99%
“…He also pointed out that randomised control trials (RCTs) on the effect of OSA therapy on cardiovascular outcomes would be important in these vulnerable phenotypes [ 13 ]. Another useful tool from the perspective of phenotyping is the PWAD index, which would allow the recognition of individuals most at risk for cardiovascular disease [ 8 ].…”
Section: State Of the Art Session: Sdb And The Heart – What Is Next?mentioning
confidence: 99%
See 1 more Smart Citation